title: Regulation of Staphylococcus aureus capsular polysaccharide type 5: CO2 inhibition in vitro and in vivo.
abstract: Staphylococcus aureus capsular polysaccharide type 5 (CP5) expression was investigated in lung tissue and nasal polyps of two cystic fibrosis (CF) patients, in rats, and in vitro using ELISA and IFA. In CF tissues, S. aureus expressed protein A and teichoic acid but only 1%-5% of cells expressed CP5. When rats were challenged with CP5-positive S. aureus in the granuloma pouch model, only 1%-5% of CP5-positive cells were detectable in pouch exudates. CF and pouch isolates, however, reexpressed CP5 (70%-90% of cells) when grown in vitro with air. Addition of > or = 1% CO2 to air or to O2/N2 gas mixtures reduced CP5 expression significantly (P < .001) in a dose-dependent manner (6%-1% CP5-positive cells). The results show that S. aureus does not produce CP5 in CF airways and in rat granuloma pouches and that CO2 is an environmental signal that regulates CP5 expression.
authors.affiliation: Department of General and Environmental Hygiene, Hygiene-Institute, University of Tübingen, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Herbert
authors.forename: D
authors.initials: D
authors.lastname: Worlitzsch
authors.forename: B
authors.initials: B
authors.lastname: Dassy
authors.forename: A
authors.initials: A
authors.lastname: Boutonnier
authors.forename: J M
authors.initials: JM
authors.lastname: Fournier
authors.forename: G
authors.initials: G
authors.lastname: Bellon
authors.forename: A
authors.initials: A
authors.lastname: Dalhoff
authors.forename: G
authors.initials: G
authors.lastname: Döring
mesh_terms: D000818:Animals; D016667:Bacterial Capsules; D002245:Carbon Dioxide / Q000378:metabolism* / Q000494:pharmacology; D003550:Cystic Fibrosis / Q000382:microbiology; D006099:Granuloma / Q000382:microbiology; D006863:Hydrogen-Ion Concentration; D008168:Lung / Q000378:metabolism / Q000382:microbiology; D008297:Male; D009298:Nasal Polyps / Q000382:microbiology; D011135:Polysaccharides, Bacterial / Q000096:biosynthesis*; D051381:Rats; D017208:Rats, Wistar; D013203:Staphylococcal Infections / Q000378:metabolism* / Q000382:microbiology; D013205:Staphylococcal Protein A / Q000096:biosynthesis; D013211:Staphylococcus aureus / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism*; D013682:Teichoic Acids / Q000096:biosynthesis
chemical_list: D011135:Polysaccharides, Bacterial; D013205:Staphylococcal Protein A; D013682:Teichoic Acids; C054106:capsular polysaccharide, type 5, Staphylococcus aureus; D002245:Carbon Dioxide